A New Heart Disease Test Flings Color Genomics Into A Battle About Genetics In Medicine

Color Genomics, a Burlingame, Calif.-based startup that made a name for itself selling tests for genes that dramatically raise the risk of cancer, is moving into heart disease. In doing so, it is stepping more deeply into the continuing debate over the medical and economic value of plumbing our DNA.

Read the full post at Forbes - Pharma & Healthcare
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive